.png)
Mid-size Medtech
Market Access, Clinical Strategy, Marketing
Pre-Launch
Wound Care
Subscribe to our newsletter to receive the latest case studies.
Mid-size Medtech
Market Access, Clinical Strategy, Marketing
Pre-Launch
Wound Care
The client was preparing to launch a novel product into an insured market with established clinical guidelines.
While strong evidence existed, it was fragmented across sources and not consistently articulated for different stakeholder audiences.
The client engaged Alkemi to develop a clear, unified evidence narrative that could support adoption and ensure consistent communication across teams.
1. Reviewed and synthesized the full evidence base to identify key messages supporting product value.
2. Developed a Global Value Dossier (GVD) tailored to the needs of different stakeholder groups.
3. Facilitated a cross-functional workshop to align teams on how the evidence should be communicated and used.
Make evidence easier to understand, align, and apply across stakeholders.
“Just wanted to send an immediate thank you for the excellent training session today. It was very well received by all of us. What an amazing way to (almost) end the week! Thank you again.” - Vice President of Market Access and Reimbursement
Teams gained a shared understanding of how to articulate value across stakeholder groups.
Stakeholders aligned on how evidence should be deployed consistently in external discussions.
A unified evidence narrative supported more confident engagement and earlier uptake.